Current location：
Global(EN)
Choose your location：
The company always attaches great importance to R&D and innovation. At present, the company has a research and development team of more than 150 people, the proportion of masters and doctors is ab
The company currently has more than 10 varieties under research, mainly including DPT series combined vaccines, Hand-foot-mouth series vaccines, Pneumococcal series vaccines, MMR series live attenuate
Since its establishment, the company has independently developed 7 China-first and World-first vaccine products, and obtained 5 National New Drug Certificates, including 2 First-Class New Drug Certifi
Institute of Biophysics, Chinese Academy of Sciences Institute of Microbiology, Chinese Academy of SciencesThe Second Affiliated Hospital, Army Medical University (Xinqiao Hospital) the PLA Academy of
